What LUMOS PHARMA, INC.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| van Es-Johansson An | Director | Dec 12 | Disposition to Issuer · D | −1,100 | — | — | 0 |
| Zoth Lota S | Director | Dec 12 | Disposition to Issuer · D | −2,187 | — | — | 0 |
| Hawkins Richard J | Chief Executive Officer | Dec 12 | Disposition to Issuer · D | −4,469 | — | — | 0 |
| Hawkins Richard J | Chief Executive Officer | Dec 12 | Disposition to Issuer · D | −753,093 | — | — | 0 |
| McCracken Joseph S | Director | Dec 12 | Disposition to Issuer · D | −15,721 | — | — | 0 |
| Lalande Kevin M. | Director | Dec 12 | Disposition to Issuer · D | −730,446 | — | — | 0 |
| Lalande Kevin M. | Director | Dec 12 | Disposition to Issuer · D | −1,076 | — | — | 0 |
| Pitukcheewanont Pisit Duke | Chief Medical Officer | Dec 12 | Disposition to Issuer · D | −16,836 | — | — | 0 |
| Lawley Lori D | Chief Financial Officer | Dec 12 | Disposition to Issuer · D | −12,284 | — | — | 0 |
| Powers Bradley J | General Counsel | Dec 12 | Disposition to Issuer · D | −27 | — | — | 0 |
| Powers Bradley J | General Counsel | Dec 12 | Disposition to Issuer · D | −6,307 | — | — | 0 |
| Schuchart Aaron | Chief Business Officer | Dec 12 | Disposition to Issuer · D | −8,179 | — | — | 0 |
| Raffin Thomas A. | Director | Dec 12 | Disposition to Issuer · D | −9,406 | — | — | 0 |
| Johnson Chad Allen | Director | Dec 12 | Disposition to Issuer · D | −1,076 | — | — | 0 |
| McKew John C. | Chief Scientific Officer | Dec 12 | Disposition to Issuer · D | −13,153 | — | — | 0 |
| McKew John C. | Chief Scientific Officer | Aug 06 | Disclosed 10b5-1 sale · S | −3,407 | $1.89 | −$6.43K | 12,653 |
| McKew John C. | Chief Scientific Officer | Aug 01 | Withheld — tax / exercise cost · F | −1,593 | $1.79 | −$2.85K | 16,060 |
| Lawley Lori D | Chief Financial Officer | Aug 01 | Withheld — tax / exercise cost · F | −229 | $1.79 | −$410 | 12,284 |
| Pitukcheewanont Pisit Duke | Chief Medical Officer | Jul 01 | Withheld — tax / exercise cost · F | −274 | $2.26 | −$620 | 16,836 |
| Pitukcheewanont Pisit Duke | Chief Medical Officer | Jun 01 | Withheld — tax / exercise cost · F | −320 | $2.25 | −$720 | 16,610 |
Loading...